Clinical Trial 44475

Canoga Park, CA 91304


Summary:

A Long-term, Randomized, Double-blind, Multicenter, Parallel-group, Phase III Study Evaluating the Efficacy and Safety of PT027 Compared to PT007 Administered as Needed in Response to Symptoms in Symptomatic Adults and Children 4 Years of Age or Older With Asthma



Criteria:
  • Be female or male aged 4 years or older at time of enrollment
  • Have a physician diagnosis of asthma documented for at least 1 year
  • Have a documented history of at least 1 severe asthma exacerbation within 12 months before Visit 1
  • Be receiving 1 of the following scheduled asthma maintenance therapies for 3 months with stable dosing for at least the 4 weeks before Visit 1:                     

                   - Medium-to-high dose inhaled corticosteroid

                   - Medium to high dose inhaled corticosteroid and 1 additional maintenance therapy from the following: LTRA, LAMA, or theophylline

                  - Low to high dose inhaled corticosteroid in combination with LABA with or without one additional maintenance therapy from the following: LTRA, LAMA, or theophylline 

  • A documented history of at least 1 severe asthma exacerbation within 12 months before Visit 1


Qualified Participants May Receive:

Compensation of $50 per visit for time and travel

All study related procedures at no cost to the participant

No charge supply of ventolin

No insurance required


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.